Investing.com - IRIDEX (NASDAQ: IRIX) reported second quarter EPS of $-0.160, $0.04 worse than the analyst estimate of $-0.120. Revenue for the quarter came in at $12.63M versus the consensus estimate of $12.9M.
IRIDEX's stock price closed at $1.87. It is down -34.150% in the last 3 months and down -4.100% in the last 12 months.
IRIDEX saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See IRIDEX's stock price’s past reactions to earnings here.
According to InvestingPro, IRIDEX's Financial Health score is "fair performance".
Check out IRIDEX's recent earnings performance, and IRIDEX's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar